Asparcam (potassium and magnesium asparaginate) ampoules 10 ml. №10

active ingredients: 1 ml of solution contains anhydrous magnesium aspartate – 40.0 mg (3.37 mg magnesium), anhydrous potassium aspartate – 45.2 mg (10.33 mg potassium);

excipients: sorbitol (E 420), water for injection.

Injection.

basic physico-chemical properties: transparent colorless or slightly yellowish liquid.

Minerals. Magnesium preparations. ATX code A12C C30.

Potassium and magnesium ions, as important intracellular cations, are involved in the work of a number of enzymes, in the process of binding macromolecules to subcellular elements, and in the mechanism of muscle contraction at the molecular level. The ratio of extra- and intracellular concentrations of potassium, calcium, sodium and magnesium ions affects the contractility of the myocardium. Aspartate, as an endogenous substance, is a carrier of potassium and magnesium ions, has a pronounced affinity for cells, and its salts undergo dissociation only slightly. As a result, ions penetrate into the intracellular space in the form of complex compounds. Magnesium and potassium asparaginate improves the metabolism of cardiac muscles. Insufficiency of the intake of potassium and magnesium in the body causes the development of arterial hypertension, pathology of the coronary vessels of the sclerotic type, heart rhythm disturbances,

• For additional therapy in chronic heart diseases (with heart failure, in the post-infarction period), with cardiac arrhythmias, especially with ventricular arrhythmias;
• additional therapy in the treatment of digitalis preparations.

• Hypersensitivity to the components of the drug;
• acute and chronic renal failure;
• Addison’s disease;
• atrioventricular block III degree;
• cardiogenic shock (BP<90 mm Hg).